NORADRENALINE DEPLETION IN PATIENTS WITH CORONARY-ARTERY DISEASE BEFORE AND AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY WITH I-123METAIODOBENZYLGUANIDINE AND SINGLE-PHOTON EMISSION TOMOGRAPHY
C. Guertner et al., NORADRENALINE DEPLETION IN PATIENTS WITH CORONARY-ARTERY DISEASE BEFORE AND AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY WITH I-123METAIODOBENZYLGUANIDINE AND SINGLE-PHOTON EMISSION TOMOGRAPHY, European journal of nuclear medicine, 20(9), 1993, pp. 776-782
Iodine-123 metaiodobenzylguanidine (MIBG) is a noradrenaline analogue
which can be used as a tracer to investigate the cardiac sympathetic n
ervous system. Regional ischaemia leads to noradrenaline depletion wit
h functional denervation which can be demonstrated by reduced MIBG upt
ake. In order to evaluate the reversibility of ischaemia-associated da
mage to the sympathetic nervous system, neuronal scintigraphy with I-1
23-MIBG and myocardial rest and stress perfusion scintigraphy with tec
hnetium-99m sestamibi was performed in 16 patients with coronary arter
y disease before and 3-4 months after percutaneous transluminal corona
ry angioplasty (PTCA). Partial re-innervation ocurred in five patients
, the degree of stenosis of remaining lesions being estimated by repea
t angiography to be below 40%. Unchanged MIBG defects cold be confirme
d in four patients with residual lesions of between 40% and 50%. Incre
ased MIBG defects were shown in three patients with significant resten
oses of more than 70%. In all patients the neuronal defects exceeded t
he ischaemia-induced or scar-associated perfusion defects. Three patie
nts dropped out of this study: one for technical reasons, one due to e
mergency aortocoronary bypass surgery and one due to diabetic polyneur
opathy. This investigation shows that the sympathetic nervous system i
s highly sensitive to ischaemia. Further studies need to be done to as
sess the conditions allowing re-innervation after PTCA.